Captopril prevention project--what shall we do about captopril and the risk of stroke?
Fournier
A
A
Pruna
A
A
Esper
N E
NE
Makdassi
R
R
Oprisiu
R
R
Westeel
P F
PF
Mazouz
H
H
Achard
J M
JM
D000804:Angiotensin II / Q000494:pharmacology; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use; D002545:Brain Ischemia / Q000517:prevention & control; D002216:Captopril / Q000494:pharmacology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D020521:Stroke / Q000517:prevention & control*
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D000804:Angiotensin II; D002216:Captopril